Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania

Withdrawn before enrolling · Phase 4 · Has a placebo group

Conditions studied: Bipolar I Disorder

In brief

The proposed pilot study is a placebo-controlled, parallel group, randomized clinical trial comparing two treatment strategies in adolescents with mania and prominent psychotic features. One group will receive a second generation antipsychotic (SGA) and placebo and the other will receive a SGA and lithium. The primary double-blind phase of the study will last 8 weeks, followed by a 24-week extension-phase.

Key facts

Study ID
NCT01495156
Run by
Northwell Health
People needed
0
Starts
2011-09-01
Expected to finish
2015-09-01
Last updated by the study team
2014-01-22

Who can join

Age: 12 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.